Parkinson Study Group

Parkinson Study Group is North America's largest non-profit clinical trial site network dedicated to advancing Parkinson's disease research. Partnering with pharmaceutical and device companies, as well as the National Institute of Health (NIH), Parkinson Study Group plays a pivotal role in bringing innovative drugs and devices to the market. With a strong commitment to improving the lives of individuals affected by Parkinson's, the Parkinson Study Group offers comprehensive research services, including clinical trial design consultation, support throughout the FDA approval process, and statistical analysis.

Leveraging a network of over 155 sites across North America, Parkinson Study Group facilitates the execution and oversight of clinical trials. Parkinson Study Group is committed to fostering the growth of early-career clinicians and coordinators specializing in movement disorders. The company provides various mentorship programs and grants to its members, further solidifying its role as a leader in Parkinson's disease research and development.

Parkinson Study Group’s mission extends beyond clinical trials to encompass the broader development of the movement disorders field. With a rich history dating back to its founding in 1986, Parkinson Study Group continues to drive progress in the understanding and treatment of Parkinson's disease. We invite the management of Parkinson Study Group to create a customized and exclusive company showcase and product listing on our platform.